Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic: A statement from the EAACI‐section on pediatrics

Brough, Helen A.; Kalaycı, Ömer; Šedivá, Anna; Untersmayr, Eva; Munblit, Daniel; Río, Pablo Rodríguez del; Vazquez‐Ortiz, Marta; Arasi, Stefania; Alvaro‐Lozano, Montserrat; Tsabouri, Sophia; Galli, Elena; Beken, Burçin; Eigenmann, Philippe

doi:10.1111/pai.13262

Cited by 101 publications

(167 citation statements)

References 35 publications

Supporting

Mentioning

152

Contrasting

Unclassified

Order By: Relevance

“…Our second search yielded 34 results in PubMed. Of those, five were primary studies that reported on asthma in adults 21‐25 ; one other was a guidance statement 26 that referenced a primary report that also included information on asthma in adults 27 . No studies from that search included information on asthma in children, although one case series reported two young children (ages 2 and 3 years) with history of atopic dermatitis and allergic rhinitis, who were hospitalized with COVID‐19; both patients recovered 28…”

Section: Resultsmentioning

confidence: 99%

Asthma and COVID‐19 in children: A systematic review and call for data

Castro-Rodriguez

Forno

2020

Pediatric Pulmonology

108

View full text Add to dashboard Cite

Rationale Whether asthma constitutes a risk factor for coronavirus disease‐2019 (COVID‐19) is unclear. Here, we aimed to assess whether asthma, the most common chronic disease in children, is associated with higher COVID‐19 risk or severity in pediatric populations. Methods We performed a systematic literature search in three stages: first, we reviewed PubMed, EMBASE, and CINAHL for systematic reviews of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and COVID‐19 in pediatric populations, and reviewed their primary articles; second, we searched PubMed for studies on COVID‐19 or SARS‐CoV‐2 and asthma/wheeze, and evaluated whether the resulting studies included pediatric populations; third, we repeated the second search in http://BioRxiv.org and http://MedRxiv.org to find pre‐prints that may have information on pediatric asthma. Results In the first search, eight systematic reviews were found, of which five were done in pediatric populations; none of the 67 primary studies included data on pediatric asthma as a comorbidity for COVID‐19. In the second search, we found 34 results in PubMed, of which five reported asthma in adults, but none included data on children. In the third search, 25 pre‐prints in MedRxiv included data on asthma, but none on children. We found one report by the US Centers for Disease Control and Prevention stating that 40/345 (~11.5%) children with data on chronic conditions had “chronic lung diseases including asthma,” and one from a tertiary hospital in New York that reported asthma in 11/46 (~23.9%) children hospitalized for COVID‐19. Conclusion There is scarcely any data on whether childhood asthma (or other pediatric respiratory diseases) constitute risk factors for SARS‐CoV‐2 infection or COVID‐19 severity. Studies are needed that go beyond counting the number of cases in the pediatric age range.

show abstract

Section: Resultsmentioning

confidence: 99%

Asthma and COVID‐19 in children: A systematic review and call for data

Castro-Rodriguez

Forno

2020

Pediatric Pulmonology

108

View full text Add to dashboard Cite

show abstract

“…It is not known whether inhaled corticosteroid use alters the susceptibility to COVID‐19 or the morbidity associated with it 2 . A meta‐analysis of 39 trials ( N = 11,615 children with asthma) on ICS does not support an increased risk of respiratory infection in general 32 .…”

Section: Implications For Asthma Managementmentioning

confidence: 99%

Pediatric asthma and COVID‐19: The known, the unknown, and the controversial

Abrams

Sinha

Fernandes

et al. 2020

Pediatric Pulmonology

View full text Add to dashboard Cite

The novel coronavirus disease‐2019 (COVID‐19), caused by the pathogen severe acute respiratory syndrome‐CoV‐2, is causing a global pandemic, with over 26.9 million cases and 880,000 deaths as of September 6, 2020. While there has been speculation and observational research about the impact of COVID‐19 on asthma, much remains unknown. The goal of this article is to provide a scoping review on pediatric asthma and COVID‐19 and summarize what we do and do not know from the first wave of the pandemic.

show abstract

“…Support families to access generic advice on how best to care for children and young people during the pandemic from organizations such as the World Health Organization [ 60 ] and, where available, more specific health-related advice via sources such as the International Society for Pediatric and Adolescent Diabetes [ 61 ], immunology and cancer services [ 62 - 64 ], and the Cystic Fibrosis Trust [ 65 ]…”

Section: Recommendations For Future Research and Clinical Carementioning

confidence: 99%

Psychosocial Challenges and Opportunities for Youth With Chronic Health Conditions During the COVID-19 Pandemic

Serlachius¹,

Badawy²,

Thabrew³

2020

JMIR Pediatr Parent

111

116

View full text Add to dashboard Cite

School closures, altered access to health services, and economic stress during the COVID-19 pandemic have likely had an impact on the mental and physical well-being of youth worldwide, particularly among those with chronic health conditions (CHCs). A number of challenges and opportunities have emerged during the COVID-19 pandemic for youth with CHCs. Challenges include heightened anxiety, disrupted routines, academic and social stresses associated with school closure, increased risk of domestic violence and abuse, and reduced access to physical and psychosocial support. On the other hand, opportunities include reduced academic and social stress, increased time with families, reduced access to substances, easier access to health care using technology, and opportunities to build resilience. This viewpoint paper highlights both challenges and opportunities for youth with CHCs during the pandemic and offers recommendations for further research and clinical care.

show abstract

Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – The 2020 COVID‐19 pandemic: A statement from the EAACI‐section on pediatrics

Cited by 101 publications

References 35 publications

Asthma and COVID‐19 in children: A systematic review and call for data

Asthma and COVID‐19 in children: A systematic review and call for data

Pediatric asthma and COVID‐19: The known, the unknown, and the controversial

Psychosocial Challenges and Opportunities for Youth With Chronic Health Conditions During the COVID-19 Pandemic

Contact Info

Product

Resources

About